Médico Internista y Endocrinólogo @FacMedicinaUC//MD, Endocrinology, Adrenal Team
Santiago, Chile
Joined January 2012
- Tweets111
- Following233
- Followers77
- Likes82
Pinned Tweet
Thank you @EndoSociety @EndoSocJournals for choosing our paper for the Endocrine Society Thematic Issue on Endocrine Neoplasia and Cancer 2021 #JES #cancer academic.oup.com/endocrineso…
Thomas Uslar retweeted
Real-world outcomes of finerenone in primary aldosteronism by Dipika R Mohan @ThomasUslar et al
EJE Volume 192, Issue 5, May 2025
Full article 👉 doi.org/10.1093/ejendo/lvaf0…
ESE members free via 👉 my.ese-hormones.org
#endocrinology #finerenone #primaryaldosteronism
Thomas Uslar retweeted
🎓La Beca de Excelencia del Gobierno Suizo 2025-2026 ya tiene nuevos representantes chilenos
Felicitamos a Javier Sadarangani Leiva (postdoc en Historia, Universidad de Berna) y Thomas Uslar Nawrath (research fellowship, Universidad de Zúrich) por este importante logro académico.
Thomas Uslar retweeted
Prednisone therapy (vs hydrocortisone) is associated with better quality of life in patients with #Cushing syndrome and #MACS post surgery. @MayoClinicEndo @BancosAdrenaLab @RSandooja @jasminesaini64
pubmed.ncbi.nlm.nih.gov/4031…
Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines academic.oup.com/jcem/articl…
Thomas Uslar retweeted
📄Lessons from clinical trials & real-world studies in metastatic pheochromocytomas & paragangliomas: This review explores systemic therapies like radiopharmaceuticals & TKIs, and insights for future trial design
🔗 journals.sagepub.com/doi/epd…
Thanks @renebaudrand & @ThomasUslar!
ALT Figure 1. The figure describes the mechanism of action of the therapies described in this manuscript. Therapies that are active and/or effective against MPPGL are highlighted in lavender. Therapies currently evaluated in trials are highlighted in orange. MPPGL, metastatic pheochromocytomas and paraganglioma.
Grateful to have collaborated on this important #PrimaryAldosteronism Medical Treatment Outcome Consensus. Huge thanks to @DrJunYang, Jacopo and Jessica for leading this effort! Let’s continue raising awareness of this underdiagnosed/frequent cause of #hypertension @TheLancetEndo
Thomas Uslar retweeted
New consensus on assessing Primary Aldosteronism Medical treatment Outcomes (PAMO), and PAMO in 1258 patients from 28 centres around the world. Grateful to 54 co-authors for collaborating! @Hudson_Research
@EndoSocAus @SCSMonash @A5_Adrenal @TheEndoSociety
sciencedirect.com/science/ar…
Thomas Uslar retweeted
We showed an association between markers of #PrimaryAldosteronism and left ventricular mass index in young, relatively healthy, adults @RaineStudy. How early should we screen for aldosterone excess? More to research! @Hudson_Research @HypertensionAus @WeArePAOrg @EndoSocAus
Does aldosterone affect the heart before primary aldosteronism (PA) develops? PA biomarkers linked to increased LV mass index by age 27, even w/o overt disease.Early detection could reshape treatment! @moragjyoung @markus_schlaich @RoshanAnanda2 @DrJunYang ahajournals.org/doi/abs/10.1…
Thomas Uslar retweeted
Following SST, 100% had decreased serum Ca with ~50% developed new-onset hypocalcemia. These acute reductions in bioavailable Ca are associated with lower post-SST aldosterone. Thank you @AnandVaidya17 @JeniferBrown & the team! academic.oup.com/ejendo/arti…
Thomas Uslar retweeted
Steroid Profiling and Circadian Cortisol Secretion in Patients With Mild Autonomous Cortisol Secretion: A Cross-sectional Study academic.oup.com/jcem/articl…
Congratulations @BancosAdrenaLab @jasminesaini64 @MayoClinicEndo
Thomas Uslar retweeted
Our meta-analysis found that in #LowReninHypertension, treatment with mineralocorticoid receptor antagonists lowered systolic BP to a greater extent compared to commonly used first-line antihypertensive agents. @Hudson_Research @EndoSocAus @HypertensionAus
nature.com/articles/s41371-0…
Thomas Uslar retweeted
In this primary care-based study, we showed that 116 of 261 patients had #hypertension ad #LowRenin (including 47 with #PrimaryAldosteronism). Those with low renin #hypertension may benefit from specific therapy. @Hudson_Research @EndoSocAus @SCSMonash academic.oup.com/jes/advance…
Progressive 11bHSD2 Insufficiency and Mineralocorticoid Receptor Activation as Kidney Function Declines -
Amazing collaboration Santiago 🇨🇱-Boston 🇺🇸 @renebaudrand @AnandVaidya17 Andrew Newman
Internacional Adrenal Meeting #IAM2024 @A5_Adrenal @TheEndoSociety #Endo2024
Thomas Uslar retweeted
My favourite time of the year (apart from school holidays)... catching up with friends from the adrenal (#PrimaryAldosteronism) world at the International Adrenal Meeting @A5_Adrenal in Boston. More fun anticipated at #ENDO2024! @Hudson_Research @TheEndoSociety
SAT345 - The Prevalence of Primary Aldosteronism in Incidentally Discovered Adrenocortical Adenomas Irrespective of Blood Pressure: A Prospective Cohort Study. Excelente equipo!! 💪🏻@TheEndoSociety #ENDO2024 @FJGuardaMD @renebaudrand
Clinical Update on Congenital Adrenal Hyperplasia: Recommendations from a Multidisciplinary Adrenal Program mdpi.com/2265746 #mdpijcm a través de @JCM_MDPI
Thomas Uslar retweeted
📢 ACTUALIZACIÓN EN HIPERPLASIA SUPRARRENAL CONGÉNITA #CAH @PedsEndoSociety 2022:
1️⃣ CAH-X es un subtipo de CAH causado por deleción del gen CYP21A2 + TNXB ➡️ gen quimera TNXA/TNXB
⚠️Sospecha clínica: hipermovilidad/hiperlaxitud
👁️ Tiene anomalías estructurales cardíacas ♥️ – at Madrid, Spain
